PRESTA, MARCO
PRESTA, MARCO
Dipartimento di Medicina Molecolare e Traslazionale
$\upbeta$-Galactosylceramidase in cancer: friend or foe?
2021-01-01 Presta, Marco
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy
2017-01-01 Rezzola, Sara; Nawaz, Imtiaz M.; Cancarini, Anna; Ravelli, Cosetta; Calza, Stefano; Semeraro, Francesco; Presta, Marco
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells
1996-01-01 Rusnati, Marco; Dell'Era, Patrizia; Urbinati, Chiara Eva; Tanghetti, Elena; Massardi, Ml; Nagamine, Y; Monti, Eugenio; Presta, Marco
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers
2015-01-01 Giacomini, Arianna; Matarazzo, Sara; Pagano, Katiuscia; Ragona, Laura; Rezzola, Sara; Corsini, Michela; Salle, Emanuela Di; Presta, Marco; Ronca, Roberto
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells.
1991-01-01 A., Isacchi; L., Bergonzoni; M., Statuto; Rusnati, Marco; R., Chiesa; P., Caccia; P., Sarmientos; Presta, Marco; G., Ragnotti
A novel ex vivo murine retina angiogenesis (EMRA) assay
2013-01-01 Rezzola, Sara; Belleri, Mirella; Domenico, Ribatti; Ciro, Costagliola; Presta, Marco; Semeraro, Francesco
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma
2019-01-01 Grillo, Elisabetta; DI SOMMA, Margherita; Ravelli, Cosetta; Corsini, Michela; Zammataro, Luca; Salvadori, Alberto; Presta, Marco; Mitola, STEFANIA MARIA FILOMENA
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis
2021-01-01 Grillo, E.; Corsini, M.; Ravelli, C.; di Somma, M.; Zammataro, L.; Monti, E.; Presta, M.; Mitola, S.
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma
2018-01-01 Di Somma, M.; Grillo, E.; Corsini, M.; Ravelli, C.; Zammataro, L.; Presta, M.; Mitola, S.
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma
2018-01-01 Grillo, Elisabetta; DI SOMMA, Margherita; Corsini, Michela; Ravelli, Cosetta; Zammataro, Luca; Presta, Marco; Mitola, STEFANIA MARIA FILOMENA
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis
2009-01-01 Andrés, G.; Leali, Daria; Mitola, Stefania Maria Filomena; Coltrini, Daniela; Camozzi, Maura; Belleri, Mirella; Presta, Marco
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis
2008-01-01 Andrés, G; Leali, Daria; Mitola, Stefania Maria Filomena; Coltrini, Daniela; Camozzi, M; Corsini, M; Belleri, Mirella; Hirsch, E; Schwendener, R; Christofori, G; Alcamí, A; Presta, Marco
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity.
1991-01-01 A., Isacchi; M., Statuto; R., Chiesa; L., Bergonzoni; Rusnati, Marco; P., Sarmientos; G., Ragnotti; Presta, Marco
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays
2015-01-01 Gnutti, Alessandro; Signoroni, Alberto; Leonardi, Riccardo; Corsini, Michela; Presta, Marco; Mitola, Stefania Maria Filomena
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein
2001-01-01 Rusnati, Marco; Urbinati, Chiara Eva; Musulin, B.; Ribatti, D.; Albini, A.; Noonan, D.; Marchisone, C.; Waltenberger, J.; Presta, Marco
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver.
1984-01-01 S., Ziliani; Presta, Marco; C., Mazzocchi; Mazzoleni, Giovanna; D., Calovini; G., Ragnotti
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells
2005-01-01 Urbinati, Chiara Eva; Bugatti, Antonella; M., Giacca; D., Schlaepfer; Presta, Marco; Rusnati, Marco
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells
1997-01-01 Rusnati, Marco; Tanghetti, Elena; Dell'Era, Patrizia; Gualandris, A; Presta, Marco
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers.
2008-01-01 Belleri, Mirella; Ribatti, D; Savio, M; Stivala, L. A.; Forti, L; Tanghetti, Elena; Alessi, Patrizia; Coltrini, Daniela; Bugatti, Antonella; Mitola, Stefania Maria Filomena; Nicoli, S; Vannini, V; Presta, Marco
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2
1999-01-01 Ribatti, D; Gualandris, A; Belleri, Mirella; Massardi, Ml; Nico, B; Rusnati, Marco; Dell'Era, Patrizia; Vacca, A; Roncali, L; Presta, Marco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| $\upbeta$-Galactosylceramidase in cancer: friend or foe? | 1-gen-2021 | Presta, Marco | |
| 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy | 1-gen-2017 | Rezzola, Sara; Nawaz, Imtiaz M.; Cancarini, Anna; Ravelli, Cosetta; Calza, Stefano; Semeraro, Francesco; Presta, Marco | |
| A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells | 1-gen-1996 | Rusnati, Marco; Dell'Era, Patrizia; Urbinati, Chiara Eva; Tanghetti, Elena; Massardi, Ml; Nagamine, Y; Monti, Eugenio; Presta, Marco | |
| A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers | 1-gen-2015 | Giacomini, Arianna; Matarazzo, Sara; Pagano, Katiuscia; Ragona, Laura; Rezzola, Sara; Corsini, Michela; Salle, Emanuela Di; Presta, Marco; Ronca, Roberto | |
| A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. | 1-gen-1991 | A., Isacchi; L., Bergonzoni; M., Statuto; Rusnati, Marco; R., Chiesa; P., Caccia; P., Sarmientos; Presta, Marco; G., Ragnotti | |
| A novel ex vivo murine retina angiogenesis (EMRA) assay | 1-gen-2013 | Rezzola, Sara; Belleri, Mirella; Domenico, Ribatti; Ciro, Costagliola; Presta, Marco; Semeraro, Francesco | |
| A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma | 1-gen-2019 | Grillo, Elisabetta; DI SOMMA, Margherita; Ravelli, Cosetta; Corsini, Michela; Zammataro, Luca; Salvadori, Alberto; Presta, Marco; Mitola, STEFANIA MARIA FILOMENA | |
| A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis | 1-gen-2021 | Grillo, E.; Corsini, M.; Ravelli, C.; di Somma, M.; Zammataro, L.; Monti, E.; Presta, M.; Mitola, S. | |
| A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma | 1-gen-2018 | Di Somma, M.; Grillo, E.; Corsini, M.; Ravelli, C.; Zammataro, L.; Presta, M.; Mitola, S. | |
| A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma | 1-gen-2018 | Grillo, Elisabetta; DI SOMMA, Margherita; Corsini, Michela; Ravelli, Cosetta; Zammataro, Luca; Presta, Marco; Mitola, STEFANIA MARIA FILOMENA | |
| A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis | 1-gen-2009 | Andrés, G.; Leali, Daria; Mitola, Stefania Maria Filomena; Coltrini, Daniela; Camozzi, Maura; Belleri, Mirella; Presta, Marco | |
| A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis | 1-gen-2008 | Andrés, G; Leali, Daria; Mitola, Stefania Maria Filomena; Coltrini, Daniela; Camozzi, M; Corsini, M; Belleri, Mirella; Hirsch, E; Schwendener, R; Christofori, G; Alcamí, A; Presta, Marco | |
| A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. | 1-gen-1991 | A., Isacchi; M., Statuto; R., Chiesa; L., Bergonzoni; Rusnati, Marco; P., Sarmientos; G., Ragnotti; Presta, Marco | |
| A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays | 1-gen-2015 | Gnutti, Alessandro; Signoroni, Alberto; Leonardi, Riccardo; Corsini, Michela; Presta, Marco; Mitola, Stefania Maria Filomena | |
| Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein | 1-gen-2001 | Rusnati, Marco; Urbinati, Chiara Eva; Musulin, B.; Ribatti, D.; Albini, A.; Noonan, D.; Marchisone, C.; Waltenberger, J.; Presta, Marco | |
| Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. | 1-gen-1984 | S., Ziliani; Presta, Marco; C., Mazzocchi; Mazzoleni, Giovanna; D., Calovini; G., Ragnotti | |
| alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells | 1-gen-2005 | Urbinati, Chiara Eva; Bugatti, Antonella; M., Giacca; D., Schlaepfer; Presta, Marco; Rusnati, Marco | |
| alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells | 1-gen-1997 | Rusnati, Marco; Tanghetti, Elena; Dell'Era, Patrizia; Gualandris, A; Presta, Marco | |
| alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. | 1-gen-2008 | Belleri, Mirella; Ribatti, D; Savio, M; Stivala, L. A.; Forti, L; Tanghetti, Elena; Alessi, Patrizia; Coltrini, Daniela; Bugatti, Antonella; Mitola, Stefania Maria Filomena; Nicoli, S; Vannini, V; Presta, Marco | |
| Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 | 1-gen-1999 | Ribatti, D; Gualandris, A; Belleri, Mirella; Massardi, Ml; Nico, B; Rusnati, Marco; Dell'Era, Patrizia; Vacca, A; Roncali, L; Presta, Marco |